Jake Probert
Medical Statistician and DPhil Student
Jake is a medical statistician working in a Cancer Research UK research programme on the benefits and risks of breast cancer treatments at the Clinical Trials Service Unit and Epidemiology Studies Unit (CTSU). He is primarily involved in observational studies of breast cancer and lymphomas to provide information that can be used by clinicians in clinics.
He completed his undergraduate degrees in mathematics and statistics at the University of Warwick, and his MSc in medical statistics at the University of Leicester, before joining CTSU in 2018.
Since 2022, he is also undertaking a part-time DPhil within NDPH. Jake aims to provide the information to make appropriate decisions regarding radiotherapy when treating early breast cancer.
Recent publications
-
Ki67 and breast cancer mortality in women with invasive breast cancer.
Journal article
Probert J. et al, (2023), JNCI Cancer Spectr, 7
-
Ki67 and breast cancer mortality in women with invasive breast cancer
Journal article
PROBERT J., (2023), JNCI Cancer Spectrum
-
Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study.
Journal article
Taylor C. et al, (2023), BMJ, 381
-
Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.
Journal article
Holt F. et al, (2023), Int J Radiat Oncol Biol Phys
-
Proton beam therapy for early breast cancer: a systematic review and quantitative synthesis of adverse clinical outcomes
Journal article
Holt F. et al, (2022), EUROPEAN JOURNAL OF CANCER, 175, S46 - S47